Kingworld Medicines Group Ltd 2023 SR
The report details Kingworld Medicines Group's ESG performance for 2023, focusing on its pharmaceutical, healthcare, and medical device segments. Key highlights include a 5% reduction target for exhaust gas and wastewater at its medical device subsidiary, Dong Di Xin, and the implementation of the SMART System for paperless trading and product traceability. The company maintained zero work-related fatalities and achieved high employee training rates. Socially, the Group donated over RMB 7 million through its foundation for pandemic relief, veteran care, and environmental protection.
Company: Kingworld Medicines Group Ltd
Sector: Health Care
Country: China
Year: 2023
Type: SR
Pages: 43
Kingworld Medicines Group Ltd
ESG Report
The report details Kingworld Medicines Group's ESG performance for 2023, focusing on its pharmaceutical, healthcare, and medical device segments. Key highlights include a 5% reduction target for exhaust gas and wastewater at its medical device subsidiary, Dong Di Xin, and the implementation of the SMART System for paperless trading and product traceability. The company maintained zero work-related fatalities and achieved high employee training rates. Socially, the Group donated over RMB 7 million through its foundation for pandemic relief, veteran care, and environmental protection.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees